These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4333494)

  • 21. Relationships among plasma [2-(13)C]uracil concentrations, breath (13)CO(2) expiration, and dihydropyrimidine dehydrogenase (DPD) activity in the liver in normal and dpd-deficient dogs.
    Inada M; Hirao Y; Koga T; Itose M; Kunizaki J; Shimizu T; Sato H
    Drug Metab Dispos; 2005 Mar; 33(3):381-7. PubMed ID: 15616154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man.
    Skibba JL; Beal DD; Ramirez G; Bryan GT
    Cancer Res; 1970 Jan; 30(1):147-50. PubMed ID: 5441073
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolism of hexamethylmelamine-ring-14C in rats and man.
    Worzalla JF; Kaiman BD; Johnson BM; Ramirez G; Bryan GT
    Cancer Res; 1974 Oct; 34(10):2669-74. PubMed ID: 4414651
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
    Asano N; Fukano M; Kubo M; Sato J; Ito A; Inoue T; Tsujikawa T; Ando A; Sasaki M; Yoshioka U; Koyama S; Fujiyama Y; Bamba T
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1069-73. PubMed ID: 9644322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of effect of 1-beta-D-arabinofuranosylcytosine, its 5'-palmitoyl ester, 1-beta-D-arabinofuranosyluracil, and tritiated thymidine on the viability of cultured leukemia L1210 cells.
    Wilkoff LJ; Dulmadge EA; Lloyd HH
    J Natl Cancer Inst; 1972 Mar; 48(3):685-95. PubMed ID: 5058968
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mechanism of action of ftorafur, a new antineoplastic agent].
    Meĭren DV; Belousova AK
    Vopr Med Khim; 1972; 18(3):288-93. PubMed ID: 4679596
    [No Abstract]   [Full Text] [Related]  

  • 27. Determination of labile trifluoromethyl compounds with a fluoride--ion electrode: differential analysis of 5-trifluoromethyluracil and 5-trifluoromethyl-2'-deoxyuridine.
    Rogers WI; Wilson JA
    Anal Biochem; 1969 Oct; 32(1):31-7. PubMed ID: 5398266
    [No Abstract]   [Full Text] [Related]  

  • 28. Notes on some peculiarities of enzymic processes in malignant tumours and tissues of the host.
    Shapot VS; Vornovitskaya GI; Gorozhanskaya EG; Davidova SY; Zhubanova AA; Krechetova GD; Chudinova IA
    Neoplasma; 1972; 19(4):335-40. PubMed ID: 4341020
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical effect of UFT on bladder cancer].
    Asahi T; Matsumura Y; Ozaki Y; Yoshimoto J; Kaneshige T; Kumon H; Tsushima T; Ohmori H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):503-7. PubMed ID: 6820901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species differences in the physiological disposition of 3-tritylthio-L-alanine (NSC83265).
    Coffey JJ; Palm PE; Denine EP; Baronowsky PE; Kensler CJ
    Cancer Res; 1971 Dec; 31(12):1908-14. PubMed ID: 5000977
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of urinary uracil measurement following administration of DPD inhibitory fluoropyrimidine(DIF)products].
    Horiuchi T; Shono Y; Miyabe T; Nakajima Y; Akiyama I; Uchida K; Fujita Y; Hasegawa K; Tabuse K
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):683-6. PubMed ID: 19381049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diphenylhydantoin on cortisol kinetics in humans.
    Choi Y; Thrasher K; Werk EE; Sholiton LJ; Olinger C
    J Pharmacol Exp Ther; 1971 Jan; 176(1):27-34. PubMed ID: 4936459
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experience report on the use of a new cytostatic 3393].
    Anger G; Hesse P; Köhler P; Baufeld H
    Z Gesamte Inn Med; 1968 Apr; 23(8):242-7. PubMed ID: 4883140
    [No Abstract]   [Full Text] [Related]  

  • 34. Neoplasms in infants: a report of 265 cases.
    Isaacs H
    Pathol Annu; 1983; 18 Pt 2():165-214. PubMed ID: 6326024
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of catabolism in pyrimidine utilization for nucleic acid synthesis in vivo.
    Cooper GM; Dunning WF; Greer S
    Cancer Res; 1972 Feb; 32(2):390-7. PubMed ID: 5058194
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular targeted therapies in hepatocellular carcinoma: from pre-clinical models to clinical trials.
    Newell P; Villanueva A; Llovet JM
    J Hepatol; 2008 Jul; 49(1):1-5. PubMed ID: 18486262
    [No Abstract]   [Full Text] [Related]  

  • 37. Megestrol treatment in patients with hepatocellular carcinoma.
    Farinati F; Gianni S; De Giorgio M; Fiorentini S
    Br J Cancer; 2001 Nov; 85(10):1606-8. PubMed ID: 11720452
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical and pharmacological studies with asparaginase in man.
    Ohnuma T; Holland JF; Freeman A; Sinks LF
    Cancer Res; 1970 Sep; 30(9):2297-305. PubMed ID: 4920133
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nucleoside as an antineoplastic agent].
    Ikehara M; Ubasawa S
    Saishin Igaku; 1970 May; 25(5):1028-38. PubMed ID: 4912176
    [No Abstract]   [Full Text] [Related]  

  • 40. Trial of adriamycin in primary hepatocellular carcinoma.
    Tsega E
    Ethiop Med J; 1984 Jan; 22(1):55-9. PubMed ID: 6317377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.